Tag: intranasal delivery

Neffy Intranasal Epinephrine Device

ARS Pharmaceuticals Announces New Patent on ARS-1 (Epinephrine Nasal Spray)

Intranasal delivery of emergency epinephrine takes another step closer to becoming a reality.
Bryn Pharma Intranasal Epinephrine Device

Intra-Nasal Epinephrine Takes Step Forward After Three Positive Pre-Clinical Studies

Intranasal delivery of epinephrine would eliminate the needle and by doing so remove a potential psychological barrier to prompt administration in an emergency.
Nose

Bryn Study Evaluates Effects of Nasal Congestion on Intranasal Administration of...

“A treatment method like intranasal delivery that is easier and more convenient may lead to increased compliance and result in a reduced time to treat an anaphylactic event.”
NanoVax Platform

BlueWillow Completes Preclinical Studies of Intranasal Peanut Allergy Vaccine

Preclinical studies of a peanut vaccine have been completed while the company has begun preclinical studies of a milk allergy vaccine and is ready to begin studies of an egg allergy vaccine.
Intranasal Spray

Study: Intranasal Epinephrine Absorbed Faster Than Injection and Even Better with...

Study compared absorption of epinephrine via nasal spray to that of intramuscular injection.
Nose

ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...

Neffy™ (formally ARS-1) was fast-tracked by the FDA in 2019 as an intranasal alternative to epinephrine auto-injectors.
Bryn Pharma Intranasal Epinephrine Device

Bryn Pharma Research on Epinephrine Nasal Spray Presented at ACAAI Annual...

Two studies shed light on the viability of intranasal delivery of emergency epinephrine.
Aptar Pharma’s BDS Device

Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment

Bryn’s epinephrine nasal spray provides two doses in one portable device.
Nose

Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support...

Nasal Spray Product is Disruptive Innovation for People at Risk of Anaphylaxis.
Opioid Crisis

How the Opioid Crisis Could Affect the Availability of Epinephrine

Pharma is under pressure to respond which has already resulted in one company seeking bankruptcy protection.